Summary
Machine-generated summaryCharite - Universitaetsmedizin Berlin intends to award a framework contract for the performance of in-vivo studies (therapy, characterisation, or biodistribution/pharmacokinetics studies) on patient-derived neuroblastoma xenograft models in mice, known as NB-PDX models, together with the harvesting of PDX tumour material. This is a framework contract with a single contractor. Special requirements apply under the Berlin procurement law (BerlAVG); further information is provided in the tender documents available on the Charite tender platform.
Description
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in German.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 19 hours ago
More from this buyer
Full buyer profileThis buyer has no award history in this sector yet. Usual winners, Research & development - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Bundesinsitut für Bau-, Stadt- und Raumforschung (BBSR) im Bundesamt für Bauwesen und Raumordnung (BBR) | 15 | €4.3M | Aug 2026 |
| Technische Universität Berlin | 5 | €1.2M | Aug 2026 |
| Prognos AG | 5 | €738,755 | May 2026 |
| Technopolis Deutschland GmbH | 5 | €604,098 | Aug 2026 |
| Öko-Institut Consult GmbH | 4 | €1.3M | Jul 2026 |
Based on 295 awards with a linked company profile over the last 2 years.
Similar tenders
Market context
- Avg. open tender · Research & development
- €3,214,242
- Buyer track record on Aperlena
- 2 notices tracked · 0 awarded
Never miss a tender like this
17 new notices in Research & development in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert